載入...
Hypopigmentation of the skin due to imatinib mesylate in patients with chronic myeloid leukemia
BACKGROUND: Hypopigmentation is an infrequently reported adverse effect of imatinib mesylate (IM) in chronic myeloid leukemia (CML), but there are no reports from Arab or Saudi patients. Thus, we assessed the frequency and impact of hypopigmentation in patients with chronic myeloid leukemia (CML) ta...
Na minha lista:
| 主要作者: | |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Elsevier
2009-04-01
|
| 叢編: | Hematology/Oncology and Stem Cell Therapy |
| 在線閱讀: | http://www.sciencedirect.com/science/article/pii/S165838760950026X |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|